Corcept Therapeutics Incorporated
CORT
|
|
|
|
Trading Volume | 38,641 |
|
38.51 - 21.10 |
Market Cap Full | $ 3.6B |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 0.9% | -22.4% | 6.7% | 11.9% |
Q2 | - | -10.9% | 2.7% | 5.6% |
Q3 | - | -8.8% | 22.5% | 7.8% |
Q4 | - | -14.8% | 23.6% | -20.8% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0.9 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-35 | 11.4 | 7.3 | -9 | - | - | - | -8.8 | - | - | - | -12.8 |
2023 | |||||||||||
12.6 | -8.9 | 4 | 4 | 4.3 | -5.3 | 14.5 | 28.5 | -16.8 | 3.1 | -9.3 | 27.5 |
2022 | |||||||||||
-6.7 | 18.8 | 1 | -5.3 | -2.3 | 14.1 | 20.5 | -9.9 | -0.7 | 11.5 | -11.6 | -19.7 |
2021 | |||||||||||
8 | -10.5 | -5.9 | -4.2 | -4.7 | 1.2 | -5.6 | 2.5 | -7.5 | -8.5 | 16.7 | -4.2 |
2020 | |||||||||||
3.6 | -0.3 | -5.5 | 6.5 | 19.6 | 11.1 | -11.1 | -15.1 | 37.1 | -3.6 | 34.9 | 15.6 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | 0.1 | 0.2 | 0.2 | 0.3 |
Q2 | 0.3 | 0.2 | 0.2 | 0.2 |
Q3 | 0.3 | 0.3 | 0.2 | 0.2 |
Q4 | 0 | 0.1 | 0.3 | 0.2 |
A | 0.67 | 0.9 | 0.9 | 0.9 |